A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS) (NCT06968741)

🧪 Interventions in This Study

• Artificial Urinary Sphincter (AUS) (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (21 Sites)

• University of California, Los Angeles — Los Angeles, California
• University of California, San Francisco — San Francisco, California
• Stanford University — Stanford, California
• Minnesota Urology — Bloomington, Minnesota
• Mayo Clinic — Rochester, Minnesota
• Wake Forest University of Health Sciences — Charlotte, North Carolina
• Duke University — Durham, North Carolina
• Cleveland Clinic Foundation — Cleveland, Ohio
• Vanderbilt University Medical Center — Nashville, Tennessee
• Urology Clinics of North Texas — Dallas, Texas
• University of Texas, Southwestern — Dallas, Texas
• University of Texas, MD Anderson — Houston, Texas
• Urology of Virginia — Virginia Beach, Virginia
• Centre Hospitalier Universitaire de Lille — Lille,
• Hospitals Academics De Marseille Conception — Marseille,
• Centre Hospitalier Universitaire de Nantes — Nantes,
• Groupe Hospitalier Pitié-Salpêtrière — Paris,
• Centre Hospitalier Univeritaire de Lyon - Hôpital Lyon Sud — Pierre-Bénite,
• Centre Hospitalier Universitaire de Rennes — Rennes,
• Centre Hospitalier Universitaire de Rouen — Rouen,
• Hopital Foch — Suresnes,

📞 Contact the Study Coordinator

Phone: (469) 766-9888

Email: roshini.jain@uromems.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Stress Urinary Incontinence (SUI)

• Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence — Phoenix, Arizona
• Baseline Knowledge of Stress Urinary Incontinence Among Urogynecology Patients — Toronto, Onatrio
• Managing Impact-related Leakage During Exercise Using Intravaginal Support — Ottawa, Ontario

Explore by condition: All Stress Urinary Incontinence (SUI) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.